Methyl salicylate 2-O-β-D-lactoside, a novel salicylic acid analogue, acts as an anti-inflammatory agent on microglia and astrocytes

BackgroundNeuroinflammation has been known to play a critical role in the pathogenesis of Alzheimer's disease (AD). Activation of microglia and astrocytes is a characteristic of brain inflammation. Epidemiological studies have shown that long-term use of non-steroidal anti-inflammatory drugs (NSAIDs) delays the onset of AD and suppresses its progression. Methyl salicylate-2-O-β-D-lactoside (DL0309) is a new molecule chemically related to salicylic acid. The present study aimed to evaluate the anti-inflammatory effects of DL0309.FindingsOur studies show that DL0309 significantly inhibits lipopolysaccharide (LPS)-induced release of the pro-inflammatory cytokines IL-6, IL-1β, and TNF-α; and the expression of the inflammation-related proteins iNOS, COX-1, and COX-2 by microglia and astrocytes. At a concentration of 10 μM, DL0309 prominently inhibited LPS-induced activation of NF-κB in glial cells by blocking phosphorylation of IKK and p65, and by blocking IκB degradation.ConclusionsWe demonstrate here for the first time that DL0309 exerts anti-inflammatory effects in glial cells by suppressing different pro-inflammatory cytokines and iNOS/NO. Furthermore, it also regulates the NF-κB signaling pathway by blocking IKK and p65 activation and IκB degradation. DL0309 also acts as a non-selective COX inhibitor in glial cells. These studies suggest that DL0309 may be effective in the treatment of neuroinflammatory disorders, including AD.

[1]  E. Benveniste Cytokines: influence on glial cell gene expression and function. , 1992, Chemical immunology.

[2]  Stephen F. Barnes The Aging Human Brain , 2010 .

[3]  M. Hüll,et al.  Synergistic inhibitory effect of ascorbic acid and acetylsalicylic acid on prostaglandin E2 release in primary rat microglia , 2003, Journal of neurochemistry.

[4]  G. Du,et al.  Gaultherin, a natural salicylate derivative from Gaultheria yunnanensis: towards a better non-steroidal anti-inflammatory drug. , 2006, European journal of pharmacology.

[5]  E. J. Green,et al.  Inhibition of astroglial nuclear factor κB reduces inflammation and improves functional recovery after spinal cord injury , 2005, The Journal of experimental medicine.

[6]  A. Mollica,et al.  Ibuprofen and Glutathione Conjugate as a Potential Therapeutic Agent for Treating Alzheimer's Disease , 2011, Archiv der Pharmazie.

[7]  K. McCarthy,et al.  Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue , 1980, The Journal of cell biology.

[8]  C. Arias,et al.  Differential effects of COX inhibitors against β-amyloid-induced neurotoxicity in human neuroblastoma cells , 2005, Neurochemistry International.

[9]  J. Chavis,et al.  The cyclopentone prostaglandin 15-deoxy-Delta(12,14) prostaglandin J2 represses nitric oxide, TNF-alpha, and IL-12 production by microglial cells. , 2001, Journal of neuroimmunology.

[10]  T. Thomas,et al.  Aspirin and non-steroidal anti-inflammatory drugs inhibit amyloid-beta aggregation. , 2001, Neuroreport.

[11]  M. Hüll,et al.  Signal transduction pathways regulating cyclooxygenase‐2 in lipopolysaccharide‐activated primary rat microglia , 2005, Glia.

[12]  J. Chavis,et al.  The cyclopentone prostaglandin 15-deoxy-Δ12,14 prostaglandin J2 represses nitric oxide, TNF-α, and IL-12 production by microglial cells , 2001, Journal of Neuroimmunology.

[13]  T. Thomas,et al.  Aspirin and non-steroidal anti-inflammatory drugs inhibit amyloid-β aggregation , 2001 .

[14]  G. Du,et al.  Anti-Inflammatory Activity of Methyl Salicylate Glycosides Isolated from Gaultheria yunnanensis (Franch.) Rehder , 2011, Molecules.

[15]  B. Winblad,et al.  Aspirin, NSAIDs, Risk of Dementia, and Influence of the Apolipoprotein E Epsilon 4 Allele in an Elderly Population , 2004, Neuroepidemiology.

[16]  T. Wyss-Coray,et al.  Adult mouse astrocytes degrade amyloid-beta in vitro and in situ. , 2003, Nature medicine.

[17]  D. Sparks,et al.  Dystrophic microglia in the aging human brain , 2004, Glia.

[18]  P. Zandi,et al.  Is pharmacological prevention of Alzheimer's a realistic goal? , 2002, Expert opinion on pharmacotherapy.

[19]  P. Magistretti,et al.  Astrocyte–neuron metabolic relationships: for better and for worse , 2011, Trends in Neurosciences.

[20]  B. Ray,et al.  Neuroinflammation in Alzheimer's disease: different molecular targets and potential therapeutic agents including curcumin. , 2009, Current opinion in pharmacology.

[21]  Tony Wyss-Coray,et al.  Inflammation in Alzheimer disease: driving force, bystander or beneficial response? , 2006, Nature Medicine.

[22]  J. Rothstein,et al.  Mechanisms of Disease: astrocytes in neurodegenerative disease , 2006, Nature Clinical Practice Neurology.